-
Study aim
-
Determining the effect of the amount of serum used on the complications after third Molar surgery
-
Design
-
Clinical trial with control group, with parallel groups, single-blind, randomized, phase 2, on 300 patients. A random number table will be used for randomization.
-
Settings and conduct
-
The aim of this study was to determine the effect of the amount of serum used on complications after third molar surgery. This study is a single blind, randomized clinical trial. The study population is patients undergoing third molar surgery. Patients will receive randomly 20, 40, and 60 ml of normal sterile saline in 3 intervention groups. The patient will be unaware of the group assigned to him.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria for participants: Patients undergoing mandibular third molar surgery, They should be in the moderate surgical group, The existence of a third mandibular molar, the occlusion of which has been confirmed by panoramic radiography.
Exclusion criteria for participants: drug use, alcohol use, smoking, the presence of underlying diseases that interfere with wound healing, such as systemic diabetes, gastrointestinal diseases, kidney disease and heart and lung disease, use of drugs that cause dry mouth.
-
Intervention groups
-
Intervention group 1: Patients will receive 20 ml of normal sterile saline.
Intervention group 2: Patients will receive 40 ml of normal sterile saline.
Intervention group 3: Patients will receive 60 ml of normal sterile saline.
-
Main outcome variables
-
Main Outcomes of the Study: Pain and Swelling.